Histomorphometric analysis of diabetic osteopenia in streptozotocin-induced diabetic mice: A possible role of oxidative stress

Bone

Volumn 40, Issue 5, 2007, Pages 1408-1414

  Hamada, Yasuhiro ^a   Kitazawa, Sohei ^a   Kitazawa, Riko ^a   Fujii, Hideki ^a   Kasuga, Masato ^a   Fukagawa, Masafumi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Diabetic osteopenia; Low turnover bone; Osteoblast; Oxidative stress; Streptozotocin

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CALCIUM; INSULIN; LINBIT; PARATHYROID HORMONE; PHOSPHORUS; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE TURNOVER; CONTROLLED STUDY; FEMUR; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; KIDNEY FUNCTION; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OSTEOPENIA; OXIDATIVE STRESS; STREPTOZOCIN DIABETES; TIBIA; TRABECULAR BONE; URINARY EXCRETION;

ANIMALS; BIOLOGICAL MARKERS; BONE DENSITY; BONE DISEASES, METABOLIC; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; STREPTOZOCIN;

EID: 34047262544     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2006.12.057     Document Type: Article

References (27)

1. Kayath M.J., Dib S.A., and Vieira J.G. Prevalence and magnitude of osteopenia associated with insulin-dependent diabetes mellitus. J. Diabetes Complications 8 (1994) 97-104
2. Kemink S.A., Hermus A.R., Swinkels L.M., Lutterman J.A., and Smals A.G. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J. Endocrinol. Invest. 23 (2000) 295-303
3. Lopez-Ibarra P.J., Pastor M.M., Escobar-Jimenez F., Pardo M.D., Gonzalez A.G., Luna J.D., et al. Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus. Endocr. Pract. 7 5 (2001 (Sep-Oct)) 346-351
4. Bouillon R. Diabetic bone disease. Calcif. Tissue Int. 49 (1991) 155-160
5. Forsen L., Meyer H.E., Midthjell K., and Edna T.H. Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey. Diabetologia 42 (1999) 920-925
6. Cozen L. Does diabetes delay fracture healing?. Clin. Orthop. Relat. Res. 82 (1972) 134-140
7. Herskind A.M., Christensen K., Norgaard-Andersen K., and Andersen J.F. Diabetes mellitus and healing of closed fractures. Diabetes Metab. 18 (1992) 63-64
8. Levin M.E., Boisseau V.C., and Avioli L.V. Effects of diabetes mellitus on bone mass in juvenile and adult-onset diabetes. N. Engl. J. Med. 294 (1976) 241-245
9. Seino Y., and Ishida H. Diabetic osteopenia: pathophysiology and clinical aspects. Diabetes Metab. Rev. 11 (1995) 21-35
10. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 46 (1995) 223-234
11. Hodgkinson A.D., Sondergaard K.L., Yang B., Cross D.F., Millward B.A., and Demaine A.G. Aldose reductase expression is induced by hyperglycemia in diabetic nephropathy. Kidney Int. 60 (2001) 211-218
12. Inoguchi T., Li P., Umeda F., Yu H.Y., Kakimoto M., Imamura M., et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49 (2000) 1939-1945
13. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404 (2000) 787-790
14. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
15. Mody N., Parhami F., Sarafian T.A., and Demer L.L. Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic. Biol. Med. 31 (2001) 509-519
16. Bai X.C., Lu D., Bai J., Zheng H., Ke Z.Y., Li X.M., et al. Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB. Biochem. Biophys. Res. Commun. 314 (2004) 197-207
17. Chen R.M., Wu G.J., Chang H.C., Chen J.T., Chen T.F., Lin Y.L., et al. 2,6-Diisopropylphenol protects osteoblasts from oxidative stress-induced apoptosis through suppression of caspase-3 activation. Ann. N. Y. Acad. Sci. 1042 (2005) 448-459
18. Fatokun A.A., Stone T.W., and Smith R.A. Hydrogen peroxide-induced oxidative stress in MC3T3-E1 cells: the effects of glutamate and protection by purines. Bone 39 (2006) 542-551
19. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2 (1987) 595-610
20. Sasaki T., Kaneko H., Ramamurthy N.S., and Golub L.M. Tetracycline administration restores osteoblast structure and function during experimental diabetes. Anat. Rec. 231 (1991) 25-34
21. Spanheimer R.G., Umpierrez G.E., and Stumpf V. Decreased collagen production in diabetic rats. Diabetes 37 (1988) 371-376
22. Weiss R.E., Gorn A.H., and Nimni M.E. Abnormalities in the biosynthesis of cartilage and bone proteoglycans in experimental diabetes. Diabetes 30 (1981) 670-677
23. Zayzafoon M., Stell C., Irwin R., and McCabe L.R. Extracellular glucose influences osteoblast differentiation and c-Jun expression. J. Cell Biochem. 79 (2000) 301-310
24. Terada M., Inaba M., Yano Y., Hasuma T., Nishizawa Y., Morii H., et al. Growth-inhibitory effect of a high glucose concentration on osteoblast-like cells. Bone 22 (1998) 17-23
25. Balint E., Szabo P., Marshall C.F., and Sprague S.M. Glucose-induced inhibition of in vitro bone mineralization. Bone 28 (2001) 21-28
26. Thrailkill K.M., Liu L., Wahl E.C., Bunn R.C., Perrien D.S., Cockrell G.E., et al. Bone formation is impaired in a model of type 1 diabetes. Diabetes 54 (2005) 2875-2881
27. Bouillon R., Bex M., Van Herck E., Laureys J., Dooms L., Lesaffre E., et al. Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus. J. Clin. Endocrinol. Metab. 80 (1995) 1194-1202